Breaking News Instant updates and real-time market news.

SSNLF

Samsung

$0.00

(0.00%)

, SPOT

Spotify

$183.38

4.68 (2.62%)

12:08
08/09/18
08/09
12:08
08/09/18
12:08

Samsung, Spotify announce music streaming partnership, Bloomberg says

Spotify (SPOT) will be deeply integrated into Samsung (SSNLF) devices, including Samsung Speaker, at setup, Bloomberg added.

SSNLF

Samsung

$0.00

(0.00%)

SPOT

Spotify

$183.38

4.68 (2.62%)

  • 10

    Sep

SSNLF Samsung
$0.00

(0.00%)

06/20/18
DADA
06/20/18
NO CHANGE
Target $125
DADA
Buy
MKS Instruments offers strong operating leverage, says DA Davidson
DA Davidson analyst Thomas Diffely kept his Buy rating and $125 price target on MKS Instruments (MKSI), saying he is turning more bullish after the company's analyst meeting yesterday. Diffely cites the company's earnings power at over $11.50 by 2021 from the continuation of its strong operating leverage as well as an "extremely bullish" 2019 WFE industry projection of $62B. Despite this positive takeaway, the analyst is also trimming his Q3 EPS estimates to $1.86 from $2.08 due to a recent pushout of 3D NAND investments at Samsung (SSNLF).
06/21/18
DADA
06/21/18
NO CHANGE
Target $90
DADA
Buy
Advanced Energy price target lowered to $90 from $100 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Advanced Energy (AEIS) to $90, citing the impact from the projected pushout of 3D NAND at Samsung (SSNLF). The analyst keeps his Buy rating however, saying that the long term bullish story on the stock is still intact, with growth driven by market demand, technology, and operations. Diffely also contends that investor concerns about "rolling over" semiconductor industry are overblown.
06/22/18
NEED
06/22/18
DOWNGRADE
NEED
Hold
KLA-Tencor downgraded to Hold at Needham on increased foundry investment risk
As reported earlier, Needham analyst Y. Edwin Mok downgraded KLA-Tencor (KLAC) to Hold from Buy, saying his recent checks indicate a heightened risk for slower foundry investments in the second half of 2018. Mok says he is still positive on the company's longer-term prospects, but its foundry delays and DRAM memory push-out reported by Samsung (SSNLF) will pressure earnings for the rest of the year while limiting near-term price appreciation.
07/20/18
CHLM
07/20/18
NO CHANGE
Target $120
CHLM
Buy
Skyworks price target raised to $120 from $115 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Skyworks (SWKS) and raised his price target to $120 after the company reported results and guidance above estimates, telling investors in a research note that he believes guidance would have been even higher if not for significant weakness at Samsung (SSNLF). Additionally, Stoss continues to believe Apple (AAPL) builds will be more front-end loaded. 5G is set to impact infrastructure in 2H2019 and smartphones in 2020, he adds, producing another step function higher in content per phone.
SPOT Spotify
$183.38

4.68 (2.62%)

07/27/18
STFL
07/27/18
NO CHANGE
Target $225
STFL
Buy
Spotify price target raised to $225 from $200 at Stifel
Stifel analyst John Egbert said Spotify's Q2 results show the company's continued momentum along with "no discernable impact" from competition. He now expects Spotify to add more net subscribers in 2018 than 2017, adding that the company's peak subscriber growth year could still be ahead of it. Egbert, who raised his subscriber and gross margin forecasts for 2018 and 2019, increased his price target on Spotify to $225 from $200 and keeps a Buy rating on the shares.
07/27/18
WELS
07/27/18
NO CHANGE
Target $180
WELS
Market Perform
Spotify price target raised to $180 from $150 at Wells Fargo
Wells Fargo analyst Peter Stabler raised his price target for Spotify Technology to $180 saying the company posted an in-line quarter that featured premium subscriber growth at the high end of guidance. The analyst, however, keeps a Market Perform rating on the shares citing valuation.
07/27/18
RILY
07/27/18
NO CHANGE
Target $200
RILY
Neutral
Spotify price target raised to $200 from $156 at B. Riley FBR
B. Riley FBR analyst Barton Crockett raised his price target for Spotify Technology to $200 after updating his estimates following the company's Q2 results. The analyst reiterates a Neutral rating on the shares.
07/30/18
BOFA
07/30/18
NO CHANGE
Target $230
BOFA
Buy
Spotify price target raised to $230 from $195 at BofA/Merrill
BofA/Merrill analyst Jessica Reif raised her price target on Spotify to $230 after the company's Q2 results that showed improving subscription gains offset in part by "softer" average revenue per user and "lighter" monthly active user count. The analyst is also positive on Spotify's stable geographic diversification of sales and a "high rate of programmatic and premium video advertising growth of 44% and 28%". Reif kept her Buy rating on Spotify, anticipating continued MAU growth driven by emerging markets expansion, Family Plan adoption, and growth in historically physical markets.

TODAY'S FREE FLY STORIES

RNSDF

Renault

$0.00

(0.00%)

, NSANY

Nissan

$0.00

(0.00%)

06:36
12/12/18
12/12
06:36
12/12/18
06:36
Periodicals
Renault tells Nissan to stop contacting board members, Reuters reports »

Renault (RNSDF) has told…

RNSDF

Renault

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

UIS

Unisys

$12.72

-0.32 (-2.45%)

06:36
12/12/18
12/12
06:36
12/12/18
06:36
Recommendations
Unisys analyst commentary  »

Unisys price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIU

AC Immune

$11.58

0.63 (5.75%)

, LLY

Eli Lilly

$114.49

0.38 (0.33%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
AC Immune, Eli Lilly announce license and collaboration agreement »

AC Immune (ACIU) and Eli…

ACIU

AC Immune

$11.58

0.63 (5.75%)

LLY

Eli Lilly

$114.49

0.38 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OMI

Owens & Minor

$7.11

-0.19 (-2.60%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
Owens & Minor names Robert Snead as EVP & CFO »

Owens & Minor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$67.28

0.06 (0.09%)

06:31
12/12/18
12/12
06:31
12/12/18
06:31
Downgrade
Black Hills rating change  »

Black Hills downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$62.30

-0.28 (-0.45%)

06:30
12/12/18
12/12
06:30
12/12/18
06:30
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$70.18

0.53 (0.76%)

06:30
12/12/18
12/12
06:30
12/12/18
06:30
Downgrade
Eversource rating change  »

Eversource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

06:29
12/12/18
12/12
06:29
12/12/18
06:29
Periodicals
Google CEO faces questions from lawmakers on alleged political bias, WSJ says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

CS

Credit Suisse

$10.92

-0.09 (-0.82%)

06:27
12/12/18
12/12
06:27
12/12/18
06:27
Hot Stocks
Credit Suisse sees FY18 reported pre-tax income CHF3.2B-CHF3.4B »

Sees FY18 APAC Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$10.92

-0.09 (-0.82%)

06:25
12/12/18
12/12
06:25
12/12/18
06:25
Hot Stocks
Credit Suisse board approves buyback of up to CHF1.5B »

At its 2018 investor day,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

06:22
12/12/18
12/12
06:22
12/12/18
06:22
Periodicals
Chinese hackers behind Marriott data breach, NY Times reports »

The cyberattack on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.40

-1.46 (-2.44%)

06:20
12/12/18
12/12
06:20
12/12/18
06:20
Initiation
Six Flags initiated  »

Six Flags initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

06:20
12/12/18
12/12
06:20
12/12/18
06:20
Periodicals
Snowden, others call for Pichai to kill Google's 'Project Dragonfly,' BI reports »

NSA whistleblower Edward…

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BY

Byline Bancorp

$18.91

-0.32 (-1.66%)

06:18
12/12/18
12/12
06:18
12/12/18
06:18
Conference/Events
Byline Bancorp management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RY

Royal Bank of Canada

$69.76

-0.44 (-0.63%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Royal Bank of Canada rating change  »

Royal Bank of Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

CORT

Corcept Therapeutics

$17.16

4.18 (32.20%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Corcept Therapeutics rating change  »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$116.67

1.66 (1.44%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Lululemon rating change  »

Lululemon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BBY

Best Buy

, AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

06:16
12/12/18
12/12
06:16
12/12/18
06:16
Recommendations
Best Buy, Amazon.com analyst commentary  »

Best Buy…

BBY

Best Buy

AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

KRYS

Krystal Biotech

$23.49

0.38 (1.64%)

06:16
12/12/18
12/12
06:16
12/12/18
06:16
Initiation
Krystal Biotech initiated  »

Krystal Biotech initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.81

-0.19 (-4.75%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Initiation
Foamix initiated  »

Foamix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Periodicals
Nissan shares detailed allegations against Ghosn with Renault, FT reports »

Nissan (NSANY) has shared…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

BHC

Bausch Health

$23.09

0.25 (1.09%)

, SGYP

Synergy Pharmaceuticals

$0.34

-0.0094 (-2.69%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Hot Stocks
Bausch Health to acquire Synergy Pharmaceuticals for $200M through Chapter 11 »

Synergy Pharmaceuticals…

BHC

Bausch Health

$23.09

0.25 (1.09%)

SGYP

Synergy Pharmaceuticals

$0.34

-0.0094 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 25

    Feb

EADSY

Airbus

$0.00

(0.00%)

06:11
12/12/18
12/12
06:11
12/12/18
06:11
Periodicals
Airbus staff error led to fatal 2017 German helicopter crash, Reuters reports »

The fatal crash in 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$15.93

-0.075 (-0.47%)

06:09
12/12/18
12/12
06:09
12/12/18
06:09
Downgrade
KeyCorp rating change  »

KeyCorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

06:07
12/12/18
12/12
06:07
12/12/18
06:07
Periodicals
Senate confirms Muzinich as Deputy Treasury Secretary, WSJ reports »

The Senate has confirmed…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.